Time courses of synthesis and secretion of lipoprotein lipase (LPL) were examined in 3T3-L1 adipocytes.
LPL was glycosylated in the endoplasmic reticulum (ER) within 10 min after synthesis, and was transported after 20-30 min to the trans Golgi where it was converted to the mature form with Mr= 55,000 -58,000, which was resistant to endoglycosidase H (endo H). LPL subunits with Mr= 55,000 -58,000 appeared in the medium within 30 min after synthesis.
The effects of brefeldin A (BFA), which inhibits transport of glycoproteins in various types of cells, on secretion and glycosylation of LPL were also examined. BFA completely blocked release of LPL activity into the medium, causing accumulation of the activity in cells. The suppressive effect of BFA on release of LPL activity was reversible. BFA-treated cells synthesized LPL with Mr= 53,000 -55,000 consisting of 2 types of subunits, the main type being totally endo H-sensitive and the other partially endo Hsensitive.
No LPL subunits were secreted into the medium by BFA-treated cells. J Atheroscler Thromb, 1995 ; 2 : 46-52.
Kew words : Lipoprotein lipase, Brefeldin A, Glycosylation, Secretion Lipoprotein lipase (LPL) is synthesized by parenchymal cells in extrahepatic tissues, secreted from the cells, and located on the membrane-bound heparane sulfate of the luminal surface of vascular endothelial cells where it hydrolyzes triacylglycerol in chylomicron and very low density lipoprotein (1) (2) (3) (4) . This enzyme is a glycoprotein with two N-linked glycosylation sites (5). Human LPL has one complex type and one high-mannose type oligosaccharide chain (6), while mouse LPL has two complex type chains (7-10).
In general, proteins exported to the cell surface or secreted from the cells are glycosylated in the endoplasmic reticulum (ER) and then sequentially transported through the cis, medial, and trans Golgi, where the oligosaccharide chains are processed. Such processed glycoproteins are ultimately located on the cell surface and/or secreted.
There have been some reports on the effects of inhibitors of movement of protein from the ER to the Golgi on the activation of LPL (9, 11). Carbonyl cyanide mchlorophenylhydrazone, which blocks movement of glycoproteins from the ER to the Golgi (12, 13), caused production of inactive LPL in cultured Ob17 adipocytes (11). Monensin, an inhibitor of transport of glycoproteins from the medial to the trans Golgi (14, 15), caused accumulation of LPL activity in cultured Ob17 adipocytes (11), and cultured mouse brown adipocytes (9). These studies showed that transport of LPL from the ER to the Golgi is necessary for expression of LPL activity.
Brefeldin A (BFA), a macrolide antibiotic that strongly inhibits virus multiplication (16), was also shown to impair transport of glycoproteins in various types of cells (17) (18) (19) (20) (21) (22) (Fig. 3B) . BFA-treated cells released about 30% as much LPL activity as that released by untreated cells in 1.5 h. Pulse-chase experiments showed a single form of LPL subunits with Mr= 53,000 -55,000 in BFA-treated cells at the beginning of the chase, but the formation of subunits with Mr=55,000-58,000 was completely blocked throughout the 90-min chase (Fig. 1) . Fig. 1 Treatment of cells with BFA caused complete blockage of release of LPL subunits into the medium throughout the 90-min chase ( Fig. 2A) . BFA-treated cells incubated for 1 or 2 h with [35S] methionine also did not release any subunits of LPL (Fig. 2B) .
Effects of BFA on incorporation of [35S]methionine into total protein and LPL
Cells were incubated for 1 or 2 h with [35S]methionine in the absence or presence of BFA, and then 35S-labeled LPL in the infranatants of cell extracts was immunoprecipitated with antiserum to bovine LPL and resolved by SDS-PAGE. The amounts of [35S] methionine incorporated into total protein in BFA-treated cells increased linearly for at least 2 h, the incorporation being 88 and 82% of that into untreated cells at 1 and 2 h, respectively (Fig. 4 upper panel) . The amount of radioactivity in LPL increased with incubation time, but the increase was not linear and the radioactivity in LPL in BFA-treated cells at 1 and 2 h were 52 and 54%, respectively, of that in untreated cells at the same time point (Fig. 4 lower panel) .
Determination of the types of oligosaccharide chains of LPL
To determine the type of oligosaccharide chains of LPL, 35S-labeled LPL was digested with endo H , which cleaves high-mannose type chains (25) but not complex type chains, and the digested products were resolved by SDS-PAGE. 35S-Labeled LPL in untreated cells consisted of two groups of subunits ; Mr=53,000-55,000 and Mr= 55,000-58,000 (Fig. 1) . The heavier subunit was endo H-resistant and the others were totally and partially endo H-sensitive yielding products with Mr=50,000 and Mr= 52,000, respectively (Fig. 5) . These results confirm our previous findings (10).
BFA-treated cells synthesized only one group of subunits with Mr=53,000-55,000 (Fig. 1) . The main subunits were totally endo H-sensitive, yielding a product of Mr=50,000, whereas the other was partially endo Hsensitive, yielding a product of Mr=52,000 (Fig. 5) . 
